Status: Not yet recruiting
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria.
Participants needed: 48
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Updated: Apr 6, 2026Locations: 26
Eligibility criteria
Age ≥ 18 years old (based on the date of signing the informed consent form); [+8]
Those who currently suffer from epilepsy/myasthenia gravis or have a history of... [+19]